AKT1 and cancer: Next, we evaluated the activation of MAPK and AKT signaling pathways in dual-treated M2 cells, as these downstream signaling events are known to promote EMT-associated changes in cancer cell lines (Gonzalez and Medici, 2014; Xu et al., 2015; Liao et al., 2019).